Aptamer Group plc (APTA) ORD GBP0.0001

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Aptamer reports progress across enzyme modulation pipeline
22 August 2025 13:58
(Sharecast News) - Aptamer Group reported progress across its enzyme modulation pipeline on Friday, and confirmed strong commercial validation from a top five global pharmaceutical partner, underscoring the...
-
Aptamer secures contract extension with 'top five global pharma' partner
18 August 2025 10:30
(Sharecast News) - Biotechnology firm Aptamer said on Monday that it has secured an extension and new work order with a "top five global pharma partner".
-
Aptamer gets more commissioned work from Unilever
21 July 2025 12:47
(Sharecast News) - Aptamer Group announced on Monday that it has received additional commissioned work from Unilever to support the ongoing development of its proprietary Optimer binders for use in deodorant...
-
Aptamer raises £2m to support expanding its Optimer technology
4 July 2025 11:51
(Sharecast News) - Aptamer Group announced on Friday that it has raised £2m through a placing of new shares to support the commercial expansion of its proprietary 'Optimer' technology and advance...
-
Aptamer signs second Optimer programme contract with Unilever
30 May 2025 09:42
(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.
-
Director dealings: Conygar, Aptamer insiders buy shares
13 January 2025 14:57
(Sharecast News) - Two director share purchases disclosed to the market in London on Monday involved insiders at the Conygar Investment Company and Aptamer Group.
-
Aptamer strikes new development contract agreement
19 December 2024 10:19
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up to £155,000.
-
Aptamer appoints three new members to scientific board
6 December 2024 13:30
(Sharecast News) - Aptamer Group announced the appointment of three new members to its scientific advisory board on Friday, as it advanced the commercialisation of its 'Optimer' binders for life...
-
Aptamer reports progress since July fundraise
29 November 2024 10:46
(Sharecast News) - Aptamer Group, the developer of 'Optimer' binders for the life sciences industry, flagged solid operational progress in an update on Friday, reporting that since its £2.6m...
-
Aptamer extends contract with Unilever
3 September 2024 08:06
(Sharecast News) - Custom antibody alternatives business Aptamer said on Tuesday that it has extended its contract with household goods giant Unilever to progress its Optimer asset for deodorant development.
-
Aptamer reports success in ongoing work with Unilever
8 July 2024 10:49
(Sharecast News) - Aptamer Group, a developer of novel 'Optimer' binders for the life sciences industry, updated the market on its ongoing partnership with Unilever on Monday, aimed at creating...
-
Aptamer enters partnership with Microsaic Systems
14 June 2024 14:15
(Sharecast News) - Aptamer Group announced a partnership with Microsaic Systems on Friday, to develop a panel of Optimer binders for integration into Microsaic's water testing system.
Company announcements Announcements
-
Update on licensing and development progress
22 August 2025 07:00
Aptamer Group
-
Exercise of warrants
19 August 2025 07:00
Aptamer Group
-
Holding(s) in Company
18 August 2025 15:44
Aptamer Group
-
Contract extension with global pharma partner
18 August 2025 07:00
Aptamer Group
-
Investor Technical Webinar
8 August 2025 07:00
Aptamer Group
-
Holding(s) in Company
7 August 2025 17:24
Aptamer Group
-
Holding(s) in Company
5 August 2025 08:05
Aptamer Group
-
Investor Webinar
31 July 2025 13:29
Aptamer Group
-
Trading Update
31 July 2025 07:00
Aptamer Group
-
Holding(s) in Company
28 July 2025 12:25
Aptamer Group
-
Result of General Meeting
24 July 2025 11:48
Aptamer Group
-
Additional work commissioned by Unilever
21 July 2025 07:00
Aptamer Group
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.